TY - JOUR
T1 - The Four-Year Course of Major Depressive Disorder
T2 - The Role of Staging and Risk Factor Determination
AU - Boschloo, Lynn
AU - Schoevers, Robert A.
AU - Beekman, Aartjan T. F.
AU - Smit, Johannes H.
AU - van Hemert, Albert M.
AU - Penninx, Brenda W. J. H.
PY - 2014
Y1 - 2014
N2 - Background: Much is still unclear about the mechanisms underlying the course of major depressive disorder (MDD). This study aimed to identify risk factors that predict a poor prognosis of MDD while taking into consideration its chronicity at baseline. Methods: In patients with MDD (n = 767), we examined whether baseline clinical factors, sociodemographics, childhood trauma, personality and life events predicted the 4-year course (i.e. sustained recovery, temporary recovery and chronic course) of MDD. Baseline chronicity of MDD was taken into account by testing whether associations were different for patients with nonchronic versus chronic MDD at baseline. Results: In patients with nonchronic MDD at baseline, 27.8% developed a chronic disorder during follow-up, whereas 53.0% of patients with chronic MDD at baseline had a persistent chronic disorder during follow-up. Severity of MDD, childhood trauma and greater age were important general risk factors for a poor prognosis, independent of MDD chronicity at baseline. In contrast, low extraversion was only important for the course of nonchronic MDD at baseline, while higher education and negative life events (in patients with high neuroticism) were only relevant for the course of chronic MDD at baseline. Conclusions: One out of 4 patients with nonchronic MDD progressed to a chronic disorder, while half of the patients with chronic MDD remained chronic during follow-up. Since several risk factors for a poor prognosis differed for patients with nonchronic and chronic MDD at baseline, treatment targets should be adjusted for current chronicity of MDD. (C) 2014 S. Karger AG, Basel
AB - Background: Much is still unclear about the mechanisms underlying the course of major depressive disorder (MDD). This study aimed to identify risk factors that predict a poor prognosis of MDD while taking into consideration its chronicity at baseline. Methods: In patients with MDD (n = 767), we examined whether baseline clinical factors, sociodemographics, childhood trauma, personality and life events predicted the 4-year course (i.e. sustained recovery, temporary recovery and chronic course) of MDD. Baseline chronicity of MDD was taken into account by testing whether associations were different for patients with nonchronic versus chronic MDD at baseline. Results: In patients with nonchronic MDD at baseline, 27.8% developed a chronic disorder during follow-up, whereas 53.0% of patients with chronic MDD at baseline had a persistent chronic disorder during follow-up. Severity of MDD, childhood trauma and greater age were important general risk factors for a poor prognosis, independent of MDD chronicity at baseline. In contrast, low extraversion was only important for the course of nonchronic MDD at baseline, while higher education and negative life events (in patients with high neuroticism) were only relevant for the course of chronic MDD at baseline. Conclusions: One out of 4 patients with nonchronic MDD progressed to a chronic disorder, while half of the patients with chronic MDD remained chronic during follow-up. Since several risk factors for a poor prognosis differed for patients with nonchronic and chronic MDD at baseline, treatment targets should be adjusted for current chronicity of MDD. (C) 2014 S. Karger AG, Basel
KW - Major depressive disorder
KW - Major depression
KW - Depression
KW - Staging
KW - Prognosis
KW - TREATMENT-RESISTANT DEPRESSION
KW - MENTAL-HEALTH SURVEY
KW - NATIONAL EPIDEMIOLOGIC SURVEY
KW - CHILDHOOD LIFE EVENTS
KW - GENERAL-POPULATION
KW - ANXIETY NESDA
KW - CLINICAL CHARACTERISTICS
KW - PSYCHIATRIC-DISORDERS
KW - NETHERLANDS
KW - EPISODES
U2 - 10.1159/000362563
DO - 10.1159/000362563
M3 - Article
SN - 0033-3190
VL - 83
SP - 279
EP - 288
JO - Psychotherapy and psychosomatics
JF - Psychotherapy and psychosomatics
IS - 5
ER -